Dreamlike image representing peaceful sleep juxtaposed with breast cancer awareness.

Sleepless Nights, Higher Risk? Unpacking Sleep Apnea and Breast Cancer Aggressiveness

"A pilot study sheds light on the potential link between sleep-disordered breathing and breast cancer aggressiveness, challenging previous assumptions."


Sleep-disordered breathing (SDB), particularly obstructive sleep apnea, is a widespread condition affecting millions. Characterized by pauses in breathing during sleep, it leads to intermittent hypoxia (reduced oxygen) and fragmented sleep. While its connection to cardiovascular issues is well-established, emerging research hints at a possible link to cancer.

Breast cancer remains a leading health concern for women worldwide. Researchers are constantly seeking to understand the factors that influence its development and progression. Given that hypoxia, a hallmark of SDB, can promote tumor growth in other cancers, the question arises: could SDB play a role in breast cancer aggressiveness?

A recent pilot study explored this potential association, investigating whether markers of SDB are linked to indicators of breast cancer aggressiveness. This article delves into the study's findings, offering a clear and accessible explanation of what it means for women's health.

AI Search Multiple angles on this topic

What the Evidence Says About OSA and Breast Cancer

Research has examined whether obstructive sleep apnea (OSA) is associated with cancer incidence and mortality, including breast cancer. A study focused on women with breast or endometrial cancer set out to measure OSA in these groups and examine associations. However, the relationship between OSA and cancer remains controversial: an updated meta-analysis noted that an earlier meta-analysis had reached opposite conclusions. For breast cancer specifically, observational studies have reported an association, but whether OSA causes breast cancer remains inconclusive.

How Researchers Assess the Association

A systematic review and meta-analysis was conducted to evaluate the association between OSA and breast cancer incidence. The review was motivated in part by animal-model evidence that intermittent nocturnal hypoxia may induce carcinogenesis. Its authors also noted that epidemiological studies had reported conflicting findings, limiting firm conclusions about the association.

Early Meta-analytic Caution

A May 1, 2021 report on a systematic review and meta-analysis cautioned that finding no statistically significant relationship between obstructive sleep apnea and pancreatic cancer did not necessarily mean that no association truly existed. The observation illustrates the limits of interpreting a nonsignificant meta-analytic result as proof of absence. The source does not establish a historical milestone specific to breast cancer.

Decoding the Study: Sleep Apnea and Breast Cancer—What's the Connection?

Dreamlike image representing peaceful sleep juxtaposed with breast cancer awareness.

The study involved 83 women under 65 years old, all recently diagnosed with primary breast cancer. Researchers used home respiratory polygraphy to assess the severity of SDB, focusing on two key measures:

Apnea-Hypopnea Index (AHI): This measures the number of apneas (complete cessation of breathing) and hypopneas (significant reduction in breathing) per hour of sleep.

  • Oxygen Desaturation Index (ODI4): This indicates how often the blood oxygen level drops by at least 4% during sleep.
AI Search Multiple angles on this topic

Findings Vary by Cancer Type

A systematic review and meta-analysis reported that one study found no association between sleep-disordered breathing and breast cancer aggressiveness markers in a Spanish population. In contrast, a review of OSA and cancer described studies in which melanoma aggressiveness was related to polysomnography (PSG) indices of OSA severity. An updated meta-analysis also reported evidence linking OSA severity with breast cancer and melanoma aggressiveness, while noting heterogeneity in the published data. The sources emphasize that cancer types may behave differently under intermittent or sustained hypoxia and sleep fragmentation, supporting investigation of individual cancer associations.

A Limitation Unlikely to Explain the Null Finding

In a study of sleep-disordered breathing and breast cancer aggressiveness, the authors addressed a limitation they identified in their analysis. They argued that it would apply equally to women with more and less aggressive breast cancer. On that basis, they did not think the limitation influenced their observed lack of association.

To gauge breast cancer aggressiveness, the study looked at factors like the Ki67 proliferation index (how quickly cancer cells are dividing), hormone receptor status, Nottingham Histological Grade (a measure of tumor differentiation), tumor stage, and molecular subtypes of breast cancer.

The Verdict: A Complex Relationship

Interestingly, the study found no clear link between the severity of SDB and breast cancer aggressiveness. Whether measured by AHI or ODI4, women with more aggressive breast cancers didn't show significantly different SDB markers compared to those with less aggressive cancers. This suggests that, at least in this study population, SDB doesn't appear to be a major driver of breast cancer progression.

Several factors might explain these findings. The women in the study generally had mild SDB. It's possible that more severe SDB could have a different impact. Secondly, the study focused on women under 65; older women might experience a different relationship between SDB and breast cancer. Finally, the study used home polygraphy, which may be less sensitive than in-lab polysomnography.

While this study doesn't establish a direct link, it highlights the complexity of cancer research and the importance of further investigation. Future studies with larger sample sizes, diverse populations, and more precise SDB assessments are needed to fully understand the potential interplay between sleep-disordered breathing and breast cancer.

Where this pilot result is weakest

  • Nighttime light exposure, light-dark patterns, diet, and environmental conditions were not assessed, although the authors noted these could affect sleep and relate to breast cancer.[1]

What the study measured in women with primary breast cancer

PopulationWomen under 65 years diagnosed with primary breast cancer[2]
Sample size83[2]
SettingOncology or Breast Cancer Unit; sleep study at the Sleep Unit[2]
Effect sizeSDB prevalence was 51.2% vs 52.3% in women with more and less aggressive breast cancer[2]
p-valuep = 0.90[2]
FundingGrant from the Asociación de Neumología y Cirugía Torácica del Sur (NEUMOSUR), Grant number 1/2015[2]
Times cited24[2]

What follow-up evidence would clarify

  • Would a group with more severe SDB show different breast cancer aggressiveness markers, given the mild SDB observed in this study?[1]
  • Could unmeasured nighttime light, sleep-cycle, diet, or environmental factors help explain variation in sleep or breast cancer markers?[1]

About this Article -

Written with AI assistance from published research, and reviewed by the Mystum team. See our About page for more information.

This article is based on research published under:

DOI-LINK: 10.1371/journal.pone.0207591, Alternate LINK

Title: Association Between Sleep-Disordered Breathing And Breast Cancer Aggressiveness

Subject: Multidisciplinary

Journal: PLOS ONE

Publisher: Public Library of Science (PLoS)

Authors: Francisco Campos-Rodriguez, Antonio Cruz-Medina, Maria Jose Selma, Maria Rodriguez-De-La-Borbolla-Artacho, Adrian Sanchez-Vega, Francisco Ripoll-Orts, Carmen V. Almeida-Gonzalez, Miguel Angel Martinez-Garcia

Published: 2018-11-21

Everything You Need To Know

1

What is Sleep-disordered breathing, and why is it important?

Sleep-disordered breathing (SDB), specifically obstructive sleep apnea, involves pauses in breathing during sleep leading to intermittent hypoxia and fragmented sleep. It is important because this condition is widespread, affecting millions and it is explored for a possible link to cancer. Specifically, the study looked at the Apnea-Hypopnea Index (AHI) and Oxygen Desaturation Index (ODI4) as key measures of SDB.

2

What is the Apnea-Hypopnea Index (AHI), and what does it measure?

The Apnea-Hypopnea Index (AHI) is used to measure the severity of Sleep-disordered breathing (SDB). It measures the number of apneas (complete cessation of breathing) and hypopneas (significant reduction in breathing) per hour of sleep. The study used AHI to assess participants, offering insights for women's health and cancer awareness.

3

What is the Oxygen Desaturation Index (ODI4), and why is it significant in this context?

The Oxygen Desaturation Index (ODI4) is used to indicate how often the blood oxygen level drops by at least 4% during sleep. Researchers used this index as a measure of Sleep-disordered breathing (SDB) in a pilot study exploring the potential link to breast cancer aggressiveness. Its significance lies in the study's exploration of the relationship between sleep and breast cancer, specifically seeking to understand how SDB markers might correlate with cancer progression. An understanding of ODI4 may lead to earlier detection and intervention.

4

What does 'breast cancer aggressiveness' mean, and how was it measured in this study?

Breast cancer aggressiveness refers to how rapidly the cancer cells grow and spread. The study considered the Ki67 proliferation index, hormone receptor status, Nottingham Histological Grade, tumor stage, and molecular subtypes of breast cancer. The study used this information to determine if there was a link with Sleep-disordered breathing (SDB), which could help in understanding the progression of breast cancer in women.

5

What were the main findings regarding the relationship between Sleep-disordered breathing and breast cancer aggressiveness?

The study found no direct link between the severity of Sleep-disordered breathing (SDB) and breast cancer aggressiveness. Women with more aggressive breast cancers didn't show significantly different SDB markers (AHI or ODI4) compared to those with less aggressive cancers. This suggests that SDB may not be a major driver of breast cancer progression within the study population. However, it is important to understand this is a pilot study with a specific population, further studies may be needed.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.